Oxytocin as Adjunctive Treatment of Schizophrenia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 04 Sep 2019 Biomarkers information updated
- 19 Mar 2013 Planned number of patients changed from 50 to 40 as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.